Caution:At present, there are occasional discrepancies in the display of intellectual property rights holders and their representatives. We are working on a solution.
see.ip - Details for VERFAHREN ZUR PRÄVENTION ODER BEHANDLUNG VON AUSGELÖSTEN ENTZÜNDUNGSREAKTIONEN MIT EINEM TUMORNEKROSEFAKTOR-ALPHA-ANTAGONIST
Details for 2011710004
Up to date per 13.06.2026
Actions
Details for 2011710004
Title / Product Name
VERFAHREN ZUR PRÄVENTION ODER BEHANDLUNG VON AUSGELÖSTEN ENTZÜNDUNGSREAKTIONEN MIT EINEM TUMORNEKROSEFAKTOR-ALPHA-ANTAGONIST
Status
Granted/Registered
Protection Type
European Patent
(AT-) Application Number
2011710004
EP Publication Number
2547363
E-Number
1276307
Language
EN
PCT Number
GB11000220
Publication Date
23.01.2013 A
03.06.2020 B1
Registration Date
03.06.2020
AT Publication Date
15.06.2020
Application Date
17.02.2011
Registration Number
-
Priorities
17.02.2010
US
305500 P
IPC
A61K 39/395 20060101AFI20120926BHEP
Maximum Duration of Protection
17.02.2031
Owner
THE KENNEDY TRUST FOR RHEUMATOLOGY RESEARCHBoundary House 91 Charterhouse Street London EC1M 6HRGB
Representative
Representative
Dipl.-Ing Dr. techn. Elisabeth SchoberFlorianigasse 26/21080 WienAT
Inventor
MAZE, Mervyn2351 Green Street San Francisco, CA 94123US
FELDMAN, MarcKennedy Institute of Rheumatology Division Imperial College London The Charing Cross Hospital Campus Arthritis Research Campaign Building 65 Aspenleas Road London W6 8LHGB
TERRANDO, Niccolo175 Johnston Drive Apt. 202 San Francisco, CA 94131US
CIBELLI, MarioFlat 11 Gloucester House 21 Scott Avenue London W15 3PBGB
MA, Daqing24 Derwent Avenue Mill Hill London NW7 3DZGB
FERTLEMAN, MichaelKennedy Institute of Rheumatology Division Imperial College London The Charing Cross Hospital Campus Arthritis Research Campaign Building 65 Aspenleas Road London W6 8LHGB